Company Financials

Amneal Pharmaceuticals, Inc. Financials

United States dollar

business Amneal Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NYSE: AMRX

Market Capitalization $3.98 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 1266.00
Forward PE 13.66
Price to Sales TTM $1.36
Price to Book MRQ $-36.17
Enterprise to Revenue 2.23
Enterprise to EBITDA 10.47

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.20%
Operating Margin 11.89%
Return on Assets TTM 6.79%
Return on Equity TTM 106.73%

Income Statement

Revenue TTM $2,934,959,104
Revenue per Share TTM $9.40
Quarterly Revenue Growth 11.70%
Gross Profit TTM $1,093,702,016
EBITDA $576,119,000
Net Income to Common TTM $5,900,000
Diluted EPS TTM $0.01
Quarterly Earnings Growth YoY 11.68%

Balance Sheet

Total Cash MRQ $203,475,008
Total Cash per Share MRQ $0.65
Total Debt MRQ $
Total Debt to Equity MRQ -24.43
Current Ratio MRQ 2.13
Book Value per Share MRQ $-0.35

Cash Flow

Operating Cash Flow TTM $327,755,008
Levered Free Cash Flow TTM $218,709,248

AMRX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 314,311,000
Float Shares 191,236,395
Avg 10 Volume 1,693,560
Avg 30 Volume None
Shares Short 5,336,430
Short Ratio 3.01
Short % of Shares 2.64%
% Held by Insiders 46.43%
% Held by Institutions 49.10%

Stock Price Summary

Beta 1.37
Fifty Two Week Low $6.69
Fifty Two Week High $13.01
Fifty Two Week Change 38.63%
Day 50 MA $11.80
Day 200 MA $9.30

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date